
Metabolic Rewiring in DKD: The Role of Tubular Cells
Clinician's RoundtableMetabolic Rewiring in DKD: The Role of Tubular Cells

Exploring Drivers of DKD: Metabolic Rewiring and Mitochondrial Dysfunction
Clinician's RoundtableExploring Drivers of DKD: Metabolic Rewiring and Mitochondrial Dysfunction

Rethinking CKD Screening in the Era of New Therapies
Heart MattersRethinking CKD Screening in the Era of New Therapies

Who Should Be Tested for Chronic Kidney Disease?
Heart MattersWho Should Be Tested for Chronic Kidney Disease?

UACR in Diabetes: A Window Into Cardiorenal Risk
Diabetes DiscourseUACR in Diabetes: A Window Into Cardiorenal Risk

Who’s Most at Risk? Assessing Progression in IgAN
Clinician's RoundtableWho’s Most at Risk? Assessing Progression in IgAN
- advertisement

Breaking Silos With STAMP! Detecting Cardiorenal Risk and Integrating Nonsteroidal MRA Therapy in Patients With HF and CKD
CME/CEBreaking Silos With STAMP! Detecting Cardiorenal Risk and Integrating Nonsteroidal MRA Therapy in Patients With HF and CKD

Translating Nonsteroidal MRA Evidence Into Practice: Optimizing Cardiorenal Outcomes in Patients With CKD
CME/CETranslating Nonsteroidal MRA Evidence Into Practice: Optimizing Cardiorenal Outcomes in Patients With CKD

Personalized Treatment Strategies for Hyperkalemia: Bridging Evidence and Clinical Practice Needs
MinuteCE®Personalized Treatment Strategies for Hyperkalemia: Bridging Evidence and Clinical Practice Needs

A Case-Based Discussion on Managing Adult Patients With C3G or IC-MPGN in the Era of Complement Inhibition
CME/CEA Case-Based Discussion on Managing Adult Patients With C3G or IC-MPGN in the Era of Complement Inhibition

Hyperkalemia as a Barrier to GDMT: Why “Stopping GDMT” Is Often the Wrong Reflex
MinuteCE®Hyperkalemia as a Barrier to GDMT: Why “Stopping GDMT” Is Often the Wrong Reflex
- advertisement

Severe Active ANCA-Associated Vasculitis (GPA/MPA): Defining Disease
Medical Industry FeatureSevere Active ANCA-Associated Vasculitis (GPA/MPA): Defining Disease

Not Just for Diabetes: Broadening uACR Screening to CV Risk Populations
Conversations in CV Risk AssessmentNot Just for Diabetes: Broadening uACR Screening to CV Risk Populations

Unseen Disease: The Diagnostic Barriers to CKD and CV Risk Prevention
Conversations in CV Risk AssessmentUnseen Disease: The Diagnostic Barriers to CKD and CV Risk Prevention

Predicting the Heart’s Future: Albuminuria as a CV Warning Sign
Conversations in CV Risk AssessmentPredicting the Heart’s Future: Albuminuria as a CV Warning Sign

Heart Failure and Albuminuria: Connecting the Dots
Conversations in CV Risk AssessmentHeart Failure and Albuminuria: Connecting the Dots

Bridging the Gap: From Screening to Cardiovascular Risk Diagnosis
Conversations in CV Risk AssessmentBridging the Gap: From Screening to Cardiovascular Risk Diagnosis
- 11/19/2026
- 11/17/2026
- 11/16/2026
- 11/12/2026
- 11/10/2026
- 11/09/2026







































































